OpenAI Blog
Sep 12, 2024
Decoding genetics with OpenAI o1
Geneticist Catherine Brownstein demonstrates how OpenAI o1 can speed up the process of diagnosing rare medical challenges.
Finding the molecular switches behind new infectious diseases
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Related stories
OpenAI Blog
Sep 10
How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules
César de la Fuente’s laboratory employs Codex and ChatGPT to explore both living and extinct genomes in search of novel antimicrobial molecules. By leveraging these AI tools, the team aims to identify candidates that could help combat drug‑resistant infections.
OpenAI Blog
Jun 18
Using AI to help physicians diagnose rare genetic diseases affecting children
Researchers used an OpenAI reasoning model to help diagnose rare diseases, identifying 18 new diagnoses in previously unsolved cases.
DeepMind Blog
Jun 25, 2025
AlphaGenome: AI for better understanding the genome
Introducing a new, unifying DNA sequence model that advances regulatory variant-effect prediction and promises to shed new light on genome function — now available via API.
arXiv AI
Sep 15
LabAgent: Customize Any Research Hubs for Scientific Discoveries Using AI Agents
arXiv:2609.13437v1 Announce Type: new Abstract: Scientific research is a continuous process that emphasizes inheritance. Methods developed by predecessors are often expanded upon by new researchers t...
OpenAI Blog
Apr 16
Introducing GPT-Rosalind for life sciences research
OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
OpenAI Blog
Jan 31, 2024
Building an early warning system for LLM-aided biological threat creation
We’re developing a blueprint for evaluating the risk that a large language model (LLM) could aid someone in creating a biological threat. In an evaluation involving both biology experts and students, we found that GPT-4 provides at most a mild uplift in biological threat creation accuracy.
DeepMind Blog
May 16
Uncovering repurposed medicines to fight liver fibrosis
Stanford geneticist uses Co-Scientist to help find new treatments for chronic liver disease and liver fibrosis.
DeepMind Blog
Sep 8
AlphaGenome Atlas: A predictive map of every possible DNA letter change in the human genome
AlphaGenome Atlas is a comprehensive resource that maps the molecular effects of 9 billion single‑letter DNA variants across the human genome. It provides a predictive map of how every possible DNA letter change could influence biological function. The atlas offers researchers a detailed view of variant impacts at an unprecedented scale.
arXiv AI
Aug 10
Artificial Intelligence Can Match Domain Experts in Evidence Extraction and Critical Appraisal of Microbial Oncogenesis Research Publications
arXiv:2608. 07250v1 Announce Type: cross Abstract: Confirmed oncogenic microbes contribute significantly to cancer burden.
arXiv AI
Aug 10
Genotypic Triggers: Exposing Pharmacogenomic Blind Spots via Host-Specific Backdoors in Generative Antimicrobial Peptide Models
arXiv:2608. 06779v1 Announce Type: cross Abstract: Large Language Models (LLMs) have accelerated drug discovery, particularly in the automated design of antimicrobial peptides (AMPs).
arXiv AI
Jun 30
Accelerating scientific discovery with Co-Scientist
arXiv:2502. 18864v2 Announce Type: replace Abstract: Scientific discovery is driven by scientists generating novel hypotheses for complex problems that undergo rigorous experimental validation.